6/25/2023 0 Comments Keymo johnson![]() Those receiving chemo survived about as long - four months, on average - as those who were not. Among 386 terminally ill cancer patients, 216 were receiving palliative chemotherapy when the study began. “My oncologist colleague was surprised because she was certain chemotherapy would be beneficial.”įor the study, the researchers reanalyzed existing data from eight outpatient cancer treatment clinics. “Those who received palliative chemotherapy, even after adjustment for their better health and quality of life and treatment preferences at our baseline assessment, were worse off,” Prigerson said. “This study arose from a bet I had with an oncology fellow who had argued the benefits of palliative chemotherapy for the dying patient,” she told Reuters Health. Prigerson worked on the new study at the Center for End-of-Life Research of Weill Cornell Medical College in New York City. Prigerson said that in her experience, “palliative chemotherapy” often only makes patients sicker. They often don't realize it will not cure them (see Reuters Health story of Jhere: reut.rs/1hweUoA ). Many advanced cancer patients receive chemotherapy that is only meant to make them more comfortable. NEW YORK (Reuters Health) - Terminally ill cancer patients who received chemotherapy in the last months of life were more likely to die in an intensive care unit than those who did not receive chemo, according to a new study.
0 Comments
Leave a Reply. |